Open AccessAchromobacter xylosoxidansin idiopathic cystic bronchiectasis
Author(s) -
Anthony Bates,
Natarajan Manjula,
Raja Reddy
Publication year - 2018
Publication title -
bmj case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 26
ISSN - 1757-790X
DOI - 10.1136/bcr-2015-211610
Subject(s) - medicine , achromobacter xylosoxidans , bronchiectasis , intensive care unit , respiratory failure , mechanical ventilation , intensive care medicine , pediatrics , surgery , anesthesia , lung , genetics , bacteria , biology
This is the first case in the English language describing Achromobacter xylosoxidans in a patient with idiopathic bronchiectasis. A 66-year-old man with bronchiectasis presented with shortness of breath to the emergency department of our institution, a district hospital in the UK. His medications included long-term supplemental oxygen therapy and prophylactic azithromycin. Following 2 days admission to the respiratory unit, his saturations significantly deteriorated, and the patient was admitted to intensive care with type II respiratory failure. Following a week of intubation and ventilation, multidrug resistant A. xylosoxidans was isolated from the tracheal aspiration secretions. The patient recovered after receiving targeted intravenous antimicrobial therapy.